Methyl 2-hydroxy-3-methylbutanoate, 97%, 25g

N-Bromosuccinimide, >98%, 100g

BENZYL 4,4-DIFLUORO-3-HYDROXYPIPERIDINE-1-CARBOXYLATE, 95.0%, 50mg

6-FLUORONAPHTHALEN-1-OL, 95.0%, 250mg

D-aspartic acid, min. 98%, for biochemistry, 25 g, plastic packaging.

Methyl 5-(3-bromophenyl)-3-methylisoxazole-4-carboxylate, 95.0%, 1g

6-(2,3-dihydro-1,4-benzodioxin-6-yl)pyridazin-3-ol, 95.0%, 250mg

(6-METHYL-5-(TRIFLUOROMETHYL)PYRIDIN-3-YL)BORONIC ACID, 95.0%, 1g

2-Chloro-n-cyclohexyl-n-phenylacetamide, 97%, 10g

Ethyl 4-(3-methoxyphenyl)thiazole-2-carboxylate, 95.0%, 1g

5'-Deoxy-5-fluorocytidine, 95.0%, 10g

1-(3-Bromophenyl)-2,5-dimethyl-1H-pyrrole, 95.0%, 10g

3-Chloro-2-(methylsulfanyl)aniline, 95%, 100mg